“We’re polishing the diamond” – Krister Sandström on his First Year as CEO of Medhouse

1. “I was given the opportunity to lead a flourishing company”

When Krister looks back on his first year as CEO, one word keeps coming up: opportunities.

“I was given the opportunity to take over a flourishing company. I often compare it to an unpolished diamond. Throughout the year, we have broadened our offering and ensured that all the fantastic competence within the organization is being used to its full potential. This development means that we are increasingly acting as a strategic partner to our customers.”

Medhouse has long been an established competence partner within Life Science. But over the past year, the company has taken new steps – both in the breadth of its services and in how it collaborates with clients.

2. Young talents driving the industry forward

One of the strongest initiatives this year has been creating a natural pathway for Generation Z into the pharmaceutical industry.

“The Nordic pharmaceutical industry is facing a generational shift. We are convinced that having multiple generations in the workplace is one of the keys to success. Gen Z grew up digitally and challenges us with new perspectives. They enter the industry without preconceived ideas and enrich the culture. We are already seeing the impact in several projects started in 2025.”

Medhouse is actively investing in training, onboarding, and coaching to give young talents the best possible start in the industry.

3. From supplier to strategic partner

Medhouse positions itself as a strategic partner – not just a provider of consultants.

“Because we work with nearly 50 companies, we see market trends quickly. This allows us to tailor solutions – for example, our digital KAMs and MSLs. We also conduct market analyses and provide strategic recommendations that clients can use directly as decision support.”

The company has also seen a clear increase in demand for commercial outsourcing. More and more pharmaceutical and biotech companies are choosing to collaborate with Medhouse to operate more efficiently or establish themselves in the Nordic region.

Instead of building large in-house teams, clients gain access to Medhouse’s expertise, local presence, and a team that can scale up or down as needed.

The advantages are clear:

• faster market access

• lower risk and reduced fixed costs

• strong local understanding of healthcare, payers, and the market

• flexible and scalable support throughout the commercialization journey

This is a rapidly growing area – and one where Medhouse can make a real difference for companies seeking success in the Nordic region.Trust remains a central part of Medhouse’s work.

“Clients often highlight that we truly understand their situation. Candidates appreciate that we take the time to support them with CV development and interview preparation. It builds long-term relationships.”

4. Looking ahead – pride and vision

Krister has a positive outlook for the future and highlights several focus areas for the coming years:

• strengthening digital services and roles

• developing the strategic partner role throughout the entire commercialization chain

• continued investment in young talent

• deepened customer partnerships

“In five years, when people hear the name Medhouse, I want them to think: ‘That’s the partner of the future.’”

After a year as CEO, it’s clear that Krister Sandström is leading Medhouse with energy and optimism. With a strong focus on development, people, and value-creating partnerships, Medhouse continues to grow and strengthen its position in the Nordic Life Science landscape.